Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases

BACKGROUND: In patients with non-small cell lung cancer (NSCLC), 10%-40% will eventually develop brain metastases. We present the clinicopathologic, genomic, and biomarker landscape of a large cohort of NSCLC brain metastases (NSCLC-BM) samples. MATERIALS AND METHODS: We retrospectively analyzed 303...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Richard S P, Harries, Lukas, Decker, Brennan, Hiemenz, Matthew C, Murugesan, Karthikeyan, Creeden, James, Tolba, Khaled, Stabile, Laura P, Ramkissoon, Shakti H, Burns, Timothy F, Ross, Jeffrey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526503/
https://www.ncbi.nlm.nih.gov/pubmed/35598205
http://dx.doi.org/10.1093/oncolo/oyac094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526503/
https://www.ncbi.nlm.nih.gov/pubmed/35598205
http://dx.doi.org/10.1093/oncolo/oyac094

Ejemplares similares